Hotta et al. have been interested in the emergence of resistance to arbekacin4 ll) (ABK), which is an anti-MRSA agent in Japan widely used since its approval in 1990, because AAC(6')/APH(2")-dependent ABK resistance is major12 13) although ABKpossesses the modification sites for AAC(3), AAC(2') and AAC(6'). Therefore, they have studied about the possible emergence of AAC-dependent ABK resistance using AAC (3)14) and AAC(2')15) of Streptomyces origin. Consequently, it turned out that ABK was readily converted to 3"-N-acetylABK and 2'-NacetylABK by the AAC (3) and AAC(2'), respectively.
Interestingly, both acetylated products retained substantial antibiotic activity so that neither AAC(3) nor AAC (2') contributed to ABKresistance.
Recently, we isolated a soil actinomycete strain designated #8 as an ABK resistant and cloned a gene segment coding for an AAC(6') capable of converting ABK to 6'-iV-acetylABK with a weak antibiotic activity12'16).
Strain #8 showed a novel multiple AGresistance profile;
i.e. resistant to wide varieties of AGswith the 6'-NH2 including neomycin (NM) but sensitive to paromomycin (PRM) with the 6'-OH that is closely related in structure with NM.Usually, NM-resistant bacteria show the cross resistance to PRM. In this sense, strain #8 that is resistant to NMbut sensitive to PRMis very unusual and therefore an unknownbiochemical event is suggested to be involved in the AG resistance phenotype. Then we carried out enzymatic modification of AGsusing cell free extracts from strain #8. It turned out that not only the AGswith the 6'-NH2but also PRMwith the 6'-OH were completely converted to their acetylated products. Interestingly, as in the cases ofABK acetylations14 '15) by AAC(3) and AAC(2') of Streptomyces origin, the incubated reaction mixture of PRMapparently kept high antibiotic activity. In this paper we describe the formation of 1-7V-acetylPRM and its little contribution to PRMresistance.
Materials and Methods
General FABMSspectra were measured on a Jeol JMS-SX102 mass spectrometer. !H and 13C NMRspectra in D2Oat pD 1.5-2.2 were taken on Jeol JNX-EX400 and JMN-A500 spectrometers. *H NMRspectra were recorded using HOD (5=4.80) as an internal standard, and 13C NMRspectra supplemented with 5~10 iag/ml ofABKon a rotary shaker. Procedures hereafter were carried out at 0°C. Mycelia were harvested by centrifugation and washed twice with 30 ml of water followed by 30ml of the following buffer: 10mM
Tris^HCl, pH 7.8, 40mM NH4C1, lOniM Mg(AcO)2 and 1mM DTT. The washed and packed mycelium was disrupted by grinding with 3 volumes of A12O3together SEPT. 1999 with a small amount of deoxyribonuclease I (Sigma) powder and then extracted with 2ml of the above buffer. ribostamycin (RSM), and NM. However, the strain was specifically sensitive to 2.5^g/ml of GMand PRM.
Enzymatic Modification of AGs
When incubated in the presence of acetyl CoA with cell free extract from strain #8, all the tested AGs including PRMwere converted ( Fig. 1 and Table 1 ). PRMwas completely converted to at least two products (major and minor spots upon TLC).The reaction mixtures ofDKBand NMalso gave two clear spots upon TLC. When the antibiotic activity of the PRM reaction mixture was checked after incubation, no apparent reduction was observed (Table 1 ). The reaction mixtures ofABK, GMand NMalso showed antibiotic activity after incubation. The other reaction mixtures showed no activity. No detectable conversion of PRMand other AGs tested were observed in the presence of ATP(data not shown). lH and 13C NMRdata in D2O at pD 2.0, see Table 2 .^H and 13C chemical shift assignments were made by^^H-COSY and HMQCexperiments.
The 1-H signal at 8 3.90 shifted to lower field than that ofPRM and the C-2 (8 30.8) and C-6 (8 74.8) signals showed j8-carbon shifts due to the Afacetylation.
Based on these, the structure of the major product was determined to be 1 -TV-acetylPRM. The enzyme that catalyzed the 1-AT-acetylation of PRM was thus regarded as AAC(l). The antibacterial activity against Bacillus subtilis PCI219 by a paper disc method showed 12% activity ofPRM.
The Minor Di-7V-acetyl Products
A mixture of two minor diacetylated products, 1,2'-and Difference in Substrate Specificity between the AAC(l) and the Known One In order to knowwhether the difference in substrate specificity, if any, between the putative AAC(l) of strain #8 and the known one is present, we examined enzymatic acetylation of apramycin (APR) that is a good substrate of the known AAC(1)18). Consequently, as shown in Fig. 3 , it turned out that APRwas very slowly acetylated by the cell free extract of strain #8, comparedto the acetylation rate of PRM,suggesting the difference in substrate specificity between both AAC(l) enzymes. SEPT. 1999 Neomycin B (NM)
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Discussion Strain #8 shows multiple resistance to wide varieties of AGs with 6'-NH2. The strain is however sensitive to PRM lacking 6'-NH2. In a separate paper16), we cloned a gene segment (0.9kb) coding for AAC(6') that conferred multiple resistance to AGs with 6'-NH2 except ABKand NMof which the 6'-iV-acetyl products exhibited weak antibiotic activities. Since strain #8 was sensitive to PRM lacking 6'-NH2 so that PRMis free from 6'-7V-acetylation, we have thought that strain #8 should not have any AAC capable of modifying PRM. However, PRMwas unexpectedly acetylated and the resulting product, 1-JV- acetylPRM, showed a weak but clear antibiotic activity (12% of PRMactivity). To our knowledge, the formation and antibiotic activity of 1-JV-acetylPRM has never been shown. It was thus obvious that the 1 -N-acetylation of PRM did not cause PRMresistance. The AACthat catalyzes the l -7V-acetylation of PRMwas putatively regarded as an AAC(l) enzyme. The substrate specificity of this enzyme seems to be different from that of the known AAC(1)18), because apramycin (APR) (a good Concerning the antibiotic activity of the reaction mixture, those of ABK,GMand NMalso showed antibiotic activity after incubation. In the case of ABKand NM, it seemed very likely that 6'-7V-acetylABK4 16) and 6'-NacetylNM19) that have antibiotic activity were formed and remained. Therefore, one should be aware of that acetylation does not always result in inactivation of AGs. In the case of GMconsisting of three components GM-C1? -C2 and -Cla, there was an unconverted spot upon TLC (Fig. 1 ) that could be regarded as GM-C{ (having both 6'-C-and TV-methyl groups) known to be refractory to AAC(6 ' )2). Another point to note was the reaction mixtures of DKB, NMand PRMfor the two conversion spots upon TLC.
Actually, the mixture of l,2'-di-7V-acetyl and l,6'"-di-iVacetyl products was obtained as the minor products from the PRMreaction mixture. It seemed likely that these diacetylated products resulted from slow acetylation of 1-N-acetylPRM by the putative AAC(2') and AAC(6'")-The spots with higher Rf upon TLCof the reaction mixtures of DKBand NMmay also be diacetylation products. Based on these findings, it will be conclusive that strain #8 contains some different or multifunctional AACs in addition to AAC(6') and AAC(l).
